Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-10-19Clinical Trial Update: A Study for Patients With Schizophrenia [Phase 2]
A Phase 2 clinical trial for schizophrenia sponsored by Eli Lilly and Company has completed.
-
CLINICAL_TRIALS trial_result · 2009-10-16Clinical Trial Update: An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia [NA]
An exploratory open-label trial evaluating adjunctive L-lysine therapy for schizophrenia has completed. Sponsor: Göteborg University.
-
CLINICAL_TRIALS trial_result · 2009-10-12Clinical Trial Update: Acceptance and Commitment Therapy for Delusions [NA]
This entry reports the completion of a clinical trial evaluating Acceptance and Commitment Therapy for delusions in people with schizophreni…
-
CLINICAL_TRIALS trial_result · 2009-10-05Clinical Trial Update: Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia [Phase 3]
Phase 3 trial evaluating the effectiveness and safety of three fixed doses (25 mg eq., 100 mg eq., and 150 mg eq.) of paliperidone palmitate…
-
CLINICAL_TRIALS trial_result · 2009-09-30Clinical Trial Update: Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine [Phase 3]
Phase 3 study evaluating a therapy to prevent weight gain in patients treated with olanzapine. The trial assessed safety and efficacy, with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-09-29Clinical Trial Update: Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry [Phase 4]
A Phase 4 clinical trial evaluating quetiapine extended-release for managing psychotic aggression or agitation in adults with schizophrenia …
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: Aripiprazole Treatment of the Prodrome [NA]
The clinical trial evaluating aripiprazole for prodromal schizophrenia/psychosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Medication Adherence in Older Adults With Serious Mental Illness [NA]
The entry reports completion of a clinical trial evaluating medication adherence in older adults with serious mental illness, including schi…
-
CLINICAL_TRIALS trial_result · 2009-09-16Clinical Trial Update: Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia
This clinical trial update reports on changes in auditory verbal hallucinations in patients with schizophrenia treated with atypical antipsy…
-
CLINICAL_TRIALS trial_result · 2009-09-11Clinical Trial Update: Study of Mental Care in Spain
AstraZeneca-supported clinical trial in Spain studying mental care for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia [Phase 2]
Phase 2 study evaluating the safety and efficacy of Study Drug versus placebo for negative symptoms in schizophrenia; the trial has complete…
-
CLINICAL_TRIALS trial_result · 2009-08-26Clinical Trial Update: A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia [Phase 3]
Phase 3 study comparing rapid-acting intramuscular olanzapine to placebo in agitated patients with schizophrenia; results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-08-12Clinical Trial Update: A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia [Phase 4]
A Phase 4, placebo-controlled trial evaluated adding modafinil to clozapine in patients with schizophrenia, and the study status shows as co…
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine
A completed clinical trial evaluated prolactin changes in patients with antipsychotic-induced hyperprolactinemia after switching to quetiapi…
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Safety, PK and PD Study in Healthy Male Japanese Subjects [Phase 1]
Phase 1 safety, pharmacokinetic (PK) and pharmacodynamic (PD) study in healthy male Japanese subjects has completed; Wyeth (now Pfizer) spon…
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia [Phase 3]
A Phase 3 study assessed varenicline for improving cognitive function in patients with schizophrenia; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Study Evaluating Multiple Ascending Dose in Schizophrenia Patients [Phase 1]
Phase 1 multiple ascending dose study in schizophrenia patients was terminated; sponsor Wyeth is now part of Pfizer.
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia [Phase 4]
Phase 4 clinical trial update on early onset antipsychotic drug action in schizophrenia and related disorders; results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia [Phase 4]
This Phase 4 trial compares the efficacy and safety of risperidone oral solution with clonazepam versus haloperidol given intramuscularly fo…
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
Observational study evaluating the effectiveness of olanzapine-coated and orodispersible tablets in outpatients with schizophrenia or bipola…
-
CLINICAL_TRIALS trial_result · 2009-07-29Clinical Trial Update: Creatine Treatment in Psychiatric Disorders [Phase 3]
This Phase 3 clinical trial update reports the completion of a study evaluating creatine as a treatment for schizophrenia.
-
CLINICAL_TRIALS trial_result · 2009-07-23Clinical Trial Update: Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder [Phase 4]
A Phase 4 safety study comparing olanzapine to a comparator in schizophrenia and schizoaffective disorder has completed and results have bee…
-
CLINICAL_TRIALS trial_result · 2009-07-21Clinical Trial Update: Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder [Phase 2]
Phase 2 study evaluating the safety and tolerability of BL-1020 in hospitalized patients with schizophrenia or schizoaffective disorder has …
-
CLINICAL_TRIALS trial_result · 2009-07-13Clinical Trial Update: The Study of Atypical Antipsychotics-induced Metabolic Disturbances
A completed clinical trial evaluating metabolic disturbances linked to atypical antipsychotics in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2009-06-29Clinical Trial Update: A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam. [Phase 1]
A Phase 1 repeat-dose study of GSK1018921 in healthy volunteers and schizophrenia patients to assess safety, tolerability, pharmacokinetics …